Cargando…
Effect of Dihydropyridine Calcium Channel Blocker on Mortality of Hypertension Patients With Moderate-Severe Pulmonary Acute Respiratory Distress Syndrome: A Multicenter Retrospective Observational Cohort Study
The aim was to evaluate the effect of dihydropyridine calcium channel blocker on the prognosis for moderate-severe pulmonary acute respiratory distress syndrome in hypertension patients. DESIGN: A retrospective, observational, multicenter cohort study. SETTING: A total of 307 patients without propen...
Autores principales: | Li, Fengyuan, Gao, Chang, Chen, Jiahao, Yang, Ling, Guo, Shiqi, Jin, Dongmei, Lu, Xiaoting, Sheng, Yin, Ji, Xiaoxia, Guo, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425825/ https://www.ncbi.nlm.nih.gov/pubmed/34514419 http://dx.doi.org/10.1097/CCE.0000000000000506 |
Ejemplares similares
-
Dihydropyridine Calcium Channel Blockers and the Risk of Severe COVID-19
por: Mendez, Sean R., et al.
Publicado: (2021) -
Effective management of hypertension with dihydropyridine calcium channel blocker-based combination therapy in patients at high cardiovascular risk
por: Haller, H
Publicado: (2008) -
How to Improve Effectiveness and Adherence to Antihypertensive Drug Therapy: Central Role of Dihydropyridinic Calcium Channel Blockers in Hypertension
por: Tocci, Giuliano, et al.
Publicado: (2017) -
Risk of Myocardial Infarction With Combination Antihypertensive Regimens Including a Dihydropyridine Calcium Channel Blocker in Hypertensive Diabetics
por: Anderson, Robert J., et al.
Publicado: (2003) -
Dihydropyridine Calcium Channel Blockers Suppress the Transcription of PD-L1 by Inhibiting the Activation of STAT1
por: Pan, Xiaohui, et al.
Publicado: (2021)